Delivery of Molecular Medicine to Solid Tumors
- 23 February 1996
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 271 (5252), 1079-1080
- https://doi.org/10.1126/science.271.5252.1079
Abstract
Molecular medicine is increasing our understanding of the molecular basis of cancer and is providing new targets for therapeutic intervention. But at present we do not have appropriate ways to deliver these agents to the tumor, and without this ability their potential will not be realized. Jain proposes a three-part strategy for overcoming this obstacle to successful treatment of tumors.This publication has 9 references indexed in Scilit:
- Hyping results 'could damage' gene therapyNature, 1995
- Anticancer drugsNature, 1995
- Monoclonal Antibodies at Age 20: Promise at Last?Science, 1995
- The slowing of treatment discovery, 1965–1995Nature Medicine, 1995
- Antisense Has Growing PainsScience, 1995
- Gene Therapy's Growing PainsScience, 1995
- Barriers to Drug Delivery in Solid TumorsScientific American, 1994
- Physiologically Based Pharmacokinetic Modeling: Principles and ApplicationsJournal of Pharmaceutical Sciences, 1983
- Animal scale-upJournal of Pharmacokinetics and Biopharmaceutics, 1973